Perosphere Technologies Appoints Michelle Brennan to Board of Directors

August 2, 2023 |

3 min read

Perosphere Technologies, a private medical technologies company focused on developing next-generation coagulation diagnostics, announced the appointment of Michelle Brennan to its Board of Directors.

Respected Healthcare Executive, Michelle Brennan, Joins Perosphere’s Board of Directors to Support Company Growth and Drive Innovation

DANBURY, Conn.--(BUSINESS WIRE)-- Perosphere Technologies (Perosphere Technologies Inc.), a private medical technologies company focused on developing next-generation coagulation diagnostics, today announced the appointment of Michelle Brennan to its Board of Directors. With deep understanding of and fluency in the healthcare sector, Brennan will play a pivotal role in guiding Perosphere’s strategic direction and supporting its mission to revolutionize patient care through the development and commercialization of innovative diagnostic tools. With Brennan’s appointment, the Board will consist of six directors.

“With her extensive experience and expertise in medical devices, Michelle will be an exceptional addition to our Board of Directors,” said Dr. Sasha Bakhru, CEO of Perosphere Technologies. “She will be a key part of the outstanding group of industry leaders that will advance the company’s growth strategy as we foster a new generation of tools supporting our mission to change the practice of medicine and transform patient care.”

Brennan brings over three decades of demonstrated leadership in healthcare, including expertise in regulatory affairs, clinical trials, market access, and global commercialization directly related to medical devices. “I am honored to have been invited to join Perosphere’s Board of Directors, as we share a deeply felt commitment to saving lives, time and money while elevating the standard of patient care,” said Brennan. “Throughout my career, I have sought to drive progress that improves treatment, and the work that Perosphere is doing mirrors that commitment.”

As former Company Group Chair of Medical Devices at Johnson & Johnson, she was instrumental in driving initiatives that prioritize patient safety, comfort, and well-being while growing the division. Brennan is also the former President, Enterprise Standards & Productivity at Johnson & Johnson, where she sought to optimize systems, processes, and business models. Prior to that role, she served as Worldwide President for Ethicon Energy, also at Johnson & Johnson, where she installed a strategic leadership team to discover innovative opportunities and shape product development.

Brennan is currently on the Board of Directors of Cardinal Healthcare, a leading medical supplier in the US, and Masimo, a medical device company and previously served on the board of COUPA Software until their recent acquisition. She is based in Spearfish, South Dakota.

About Perosphere Technologies

Perosphere Technologies is changing the way decisions are made for patients at risk of bleeding. A private medical technologies company, Perosphere is focused on development and commercialization of its novel PoC (point-of-care) Coagulometer, which informs diagnosis, treatment, and prevention through precision data, made immediately accessible to all. It is the only point-of-care diagnostic tool that effectively and swiftly tests clotting times across drug classes, including DOACs. The fast diagnosis and related appropriate treatment decisions the PoC Coagulometer enables will help establish a new standard of care in hospital emergency departments for patients at risk for bleeding and has the potential to improve efficiency, provide significant cost savings, and better patient outcomes. The PoC Coagulometer has a CE Mark in the EU but is not yet cleared in the US.

For further information, contact us at info@perospheretech.com or +1 (475) 218-4600.

www.perospheretech.com